Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001085146-25-004810·COLLEGIUM PHARMACEUTICAL, INC
Schedule 13G ownership disclosure
Collegium Pharmaceutical Inc
Common stock, par value $0.001 per share · CUSIP: 19459J104
Event date: 2025-06-30
- Filing-level shares
- 1,466,506
- Percent of class
- 4.6%
- PRINCIPAL GLOBAL INVESTORS
Shares: 1,466,506 · Class: 4.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-25-004810
- Form type
- SCHEDULE 13G/A
- Filer
- COLLEGIUM PHARMACEUTICAL, INC
- CIK
- CIK 1267565
- Filed
- Aug 11, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership